Axonics, Inc. (NASDAQ:AXNX – Get Free Report) has been given a consensus recommendation of “Hold” by the twelve research firms that are currently covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year […]
Artisan Partners Limited Partnership acquired a new position in shares of Axonics, Inc. (NASDAQ:AXNX – Free Report) in the third quarter, HoldingsChannel.com reports. The institutional investor acquired 636,931 shares of the company’s stock, valued at approximately $35,745,000. A number of other institutional investors have also added to or reduced their stakes in the stock. Vanguard […]
Axonics (NASDAQ:AXNX – Get Free Report) and SeaStar Medical (NASDAQ:ICU – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, valuation, dividends, profitability and analyst recommendations. Profitability This table compares Axonics and SeaStar Medical’s net […]
Axonics, Inc. (NASDAQ:AXNX – Get Free Report) was the target of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 1,160,000 shares, a decline of 55.4% from the December 31st total of 2,600,000 shares. Based on an average daily volume of 1,050,000 shares, the […]
Shares of Axonics, Inc. (NASDAQ:AXNX – Get Free Report) have been given an average recommendation of “Hold” by the twelve research firms that are presently covering the firm, Marketbeat reports. Seven equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 […]